Acme United looks like a sleepy tools business until the filing mix shows first aid at roughly two-thirds of sales, a new My Medic deal, tariff pain, rising debt, and a customer-concentration test.
References
Sources used in this report
SEC APISEC submissions JSON2026-05-13 · Company identity, CIK, ticker, exchange, headquarters, SIC, and filing sequence.SEC APISEC companyfacts JSON2026-05-13 · XBRL cross-check for financial statement facts and share data.SEC filingFY2025 Form 10-K2026-03-11 · Business, brands, product categories, customer channels, competition, risks, segment and product revenue, annual financials, debt, liquidity, and controls.SEC filingQ1 2026 Form 10-Q2026-05-06 · Quarterly sales, earnings, cash flow, balance sheet, debt, working capital, My Medic cash impact, and covenant status.SEC-filed releaseQ1 2026 earnings release2026-04-23 · Sales growth, comparable growth, My Medic contribution, tariff pressure, Med-Nap expense, geographic commentary, debt less cash, and management actions.SEC-filed releaseFY2025 earnings release2026-02-26 · FY2025 sales, EPS, tariff impact, My Medic purchase price and revenue context, free cash flow, net debt, and dividend commentary.SEC-filed exhibitMy Medic asset purchase agreement exhibit2026-01-22 · Transaction structure, sellers, business description, purchase price, closing payment, and holdback terms.SEC filing2026 proxy statement2026-03-27 · Annual meeting, record-date shares, board, executive compensation, ownership, option-plan proposal, and auditor context.